"Better access to info crucial" for boost in new medtech use
This article was originally published in Clinica
Patient access to information on new treatment options and the condition itself is crucial to improving healthcare outcomes and even reducing healthcare costs. This is the conclusion of a survey on the value of patient information on the management of chronic disease. The survey, conducted by Pfizer, involved 4,500 patients in eight European countries (Finland, France, Germany, Italy, Poland, Spain, Sweden and the UK) and the US, focusing on the knowledge surrounding asthma, cardiovascular disease and type-2 diabetes.